You are here:Home-Chemical Inhibitors & Agonists-Cytoskeleton/Cell Adhesion Molecules-Myosin-EDG-5506
EDG-5506

Chemical Structure : EDG-5506

CAS No.: 2417395-15-2

EDG-5506 (Sevasemten, EDG5506, EDG 5506)

Catalog No.: PC-20390Not For Human Use, Lab Use Only.

EDG-5506 (Sevasemten) is a potent, selective, orally active inhibitor of fast skeletal muscle myosin, inhibits fast myofibril ATPase from rabbit psoas muscle with IC50 of 0.2 uM.

Packing Price Stock Quantity
25 mg Get quote
50 mg Get quote
100 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

EDG-5506 (Sevasemten) is a potent, selective, orally active inhibitor of fast skeletal muscle myosin, inhibits fast myofibril ATPase from rabbit psoas muscle with IC50 of 0.2 uM.
EDG-5506 is inactive against cardiac and slow bovine masseter skeletal myofibrils with an IC50 greater than 100 uM.
EDG-5506 is also a potent inhibitor of other mixed fast myosin myofibrils (mouse gastroc IC50 0.4 uM, 21% IIa, 15% IIx, 56%IIb; mouse TA IC50 0.4 uM, mixed IIa, IIx, IIb suggesting equal potency against all fast skeletal myosin proteins.
EDG-5506 inhibits the enzymatic activity of fast skeletal S1 from rabbit psoas but not porcine ventricular cardiac S1 or the more unrelated smooth muscle S1 with an IC50 of 0.11 uM and >100 uM, respectively.
EDG-5506 effectively reduces dye uptake in ex vivo lengthening contraction of mdx EDL muscle using a membrane-impermeable dye.
EDG-5506 protects skeletal muscle in mdx and DBA/2 mdx mice in vivo, with no effect on body or muscle weight.
EDG-5506 lowers disease biomarkers and improves physical function in duchenne muscular dystrophy (DMD) dogs.

Physicochemical Properties

M.Wt 381.29
Formula C16H11F4N5O2
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

2-((5-fluoropyridin-3-yl)methyl)-6-(2-(2,2,2-trifluoroethoxy)pyrimidin-5-yl)pyridazin-3(2H)-one

References

1. Russell AJ, et al. J Clin Invest. 2023 Mar 30:e153837.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: